Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Heart failure with preserved ejection fraction: from mechanisms to therapies
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week
Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.